BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yousefi N, Sotoodehnejadnematalahi F, Heshmati-Fakhr N, Sayyah M, Hoseini M, Ghassemi S, Aliakbari S, Pourbadie HG. Prestimulation of Microglia Through TLR4 Pathway Promotes Interferon Beta Expression in a Rat Model of Alzheimer's Disease. J Mol Neurosci 2019;67:495-503. [PMID: 30610591 DOI: 10.1007/s12031-018-1249-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Ernest James Phillips T, Maguire E. Phosphoinositides: Roles in the Development of Microglial-Mediated Neuroinflammation and Neurodegeneration. Front Cell Neurosci 2021;15:652593. [PMID: 33841102 DOI: 10.3389/fncel.2021.652593] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Piec PA, Pons V, Rivest S. Triggering Innate Immune Receptors as New Therapies in Alzheimer's Disease and Multiple Sclerosis. Cells 2021;10:2164. [PMID: 34440933 DOI: 10.3390/cells10082164] [Reference Citation Analysis]
3 Zhu L, Huang Y, Hu Y, Tang Q, Zhong Y. Toll-like receptor 4/nuclear factor-kappa B pathway is involved in radicular pain by encouraging spinal microglia activation and inflammatory response in a rat model of lumbar disc herniation. Korean J Pain 2021;34:47-57. [PMID: 33380567 DOI: 10.3344/kjp.2021.34.1.47] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Mizobuchi H, Soma GI. Low-dose lipopolysaccharide as an immune regulator for homeostasis maintenance in the central nervous system through transformation to neuroprotective microglia. Neural Regen Res 2021;16:1928-34. [PMID: 33642362 DOI: 10.4103/1673-5374.308067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
5 Zhou Y, Chen Y, Xu C, Zhang H, Lin C. TLR4 Targeting as a Promising Therapeutic Strategy for Alzheimer Disease Treatment. Front Neurosci 2020;14:602508. [PMID: 33390886 DOI: 10.3389/fnins.2020.602508] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Zhou C, Sun X, Hu Y, Song J, Dong S, Kong D, Wang Y, Hua X, Han J, Zhou Y, Jin G, Yang X, Shi H, Zhang Z, Hua F. Genomic deletion of TLR2 induces aggravated white matter damage and deteriorated neurobehavioral functions in mouse models of Alzheimer's disease. Aging (Albany NY) 2019;11:7257-73. [PMID: 31509519 DOI: 10.18632/aging.102260] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
7 Cui W, Sun C, Ma Y, Wang S, Wang X, Zhang Y. Neuroprotective effect of tormentic acid against memory impairment and neuro‑inflammation in an Alzheimer's disease mouse model. Mol Med Rep 2020;22:739-50. [PMID: 32468017 DOI: 10.3892/mmr.2020.11154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Paudel YN, Angelopoulou E, Piperi C, Othman I, Aamir K, Shaikh MF. Impact of HMGB1, RAGE, and TLR4 in Alzheimer's Disease (AD): From Risk Factors to Therapeutic Targeting. Cells 2020;9:E383. [PMID: 32046119 DOI: 10.3390/cells9020383] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 19.5] [Reference Citation Analysis]
9 Momtazmanesh S, Perry G, Rezaei N. Toll-like receptors in Alzheimer's disease. Journal of Neuroimmunology 2020;348:577362. [DOI: 10.1016/j.jneuroim.2020.577362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
10 Amini N, Azad RR, Motamedi F, Mirzapour-Delavar H, Ghasemi S, Aliakbari S, Pourbadie HG. Overexpression of protein kinase Mζ in the hippocampus mitigates Alzheimer's disease-related cognitive deficit in rats. Brain Res Bull 2021;166:64-72. [PMID: 33188852 DOI: 10.1016/j.brainresbull.2020.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]